Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Cardlytics, Inc. Lawsuit - CDLX

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Group 1: Allegations and Claims - The lawsuit claims that the defendants made false statements regarding consumer engagement and its impact on revenue, indicating that increased consumer engagement led to higher consumer incentives but did not result in proportional billings [2]. - It is alleged that there was a significant risk of slowing or declining revenue growth due to the inability to increase billings in line with consumer engagement [2]. - The changes to the Ads Decision Engine, which were intended to boost consumer engagement, resulted in "under-delivery" of budgets and customer billing estimates, misleading investors about the company's operational health [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, emphasizing that there is no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].